13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q2 2023 · Filed April 25, 2023 · Accession 0001104659-23-049597
Total Value
$82.6M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VENTYX BIOSCIENCES INC | 92332V107 | 746,370 | $25.0M | 30.26% |
| 2 | ICOSAVAX INC | 45114M109 | 3,510,228 | $20.4M | 24.64% |
| 3 | JASPER THERAPEUTICS INC | JSPRW | 8,519,648 | $15.4M | 18.66% |
| 4 | HILLEVAX INC | 43157M102 | 558,923 | $9.2M | 11.18% |
| 5 | TALARIS THERAPEUTICS INC | 87410C104 | 2,932,606 | $5.5M | 6.67% |
| 6 | ELEVATION ONCOLOGY INC | 28623U101 | 2,370,142 | $4.5M | 5.45% |
| 7 | KEZAR LIFE SCIENCES INC | KZR | 828,711 | $2.6M | 3.14% |